Axa’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-351,682
| Closed | -$17.9M | – | 664 |
|
|
2025
Q2 | $17.9M | Buy |
351,682
+310
| +0.1% | +$13.8K | 0.05% | 298 |
|
|
2025
Q1 | $15.8M | Sell |
351,372
-74,274
| -17% | -$3.5M | 0.05% | 308 |
|
|
2024
Q4 | $17.6M | Sell |
425,646
-422
| -0.1% | -$17.6K | 0.05% | 298 |
|
|
2024
Q3 | $16.6M | Buy |
426,068
+76
| +0% | +$3.03K | 0.05% | 310 |
|
|
2024
Q2 | $14.6M | Sell |
425,992
-167,794
| -28% | -$4.4M | 0.04% | 327 |
|
|
2024
Q1 | $14.9M | Buy |
593,786
+73
| +0% | +$2.01K | 0.04% | 331 |
|
|
2023
Q4 | $17.5M | Sell |
593,713
-23,402
| -4% | -$708K | 0.06% | 297 |
|
|
2023
Q3 | $19.5M | Sell |
617,115
-51,760
| -8% | -$1.42M | 0.07% | 277 |
|
|
2023
Q2 | $17.3M | Sell |
668,875
-219,679
| -25% | -$5.84M | 0.06% | 311 |
|
|
2023
Q1 | $21.3M | Sell |
888,554
-57,984
| -6% | -$1.32M | 0.07% | 286 |
|
|
2022
Q4 | $18.5M | Buy |
946,538
+88,327
| +10% | +$1.75M | 0.07% | 318 |
|
|
2022
Q3 | $18M | Sell |
858,211
-28,188
| -3% | -$679K | 0.07% | 299 |
|
|
2022
Q2 | $17.2M | Sell |
886,399
-97,430
| -10% | -$2.3M | 0.06% | 324 |
|
|
2022
Q1 | $21.7M | Sell |
983,829
-8,726
| -0.9% | -$178K | 0.06% | 347 |
|
|
2021
Q4 | $15.8M | Buy |
992,555
+140,383
| +16% | +$2.18M | 0.04% | 408 |
|
|
2021
Q3 | $17M | Buy |
852,172
+190,580
| +29% | +$3.1M | 0.05% | 370 |
|
|
2021
Q2 | $11.4M | Buy |
661,592
+92,610
| +16% | +$1.66M | 0.03% | 485 |
|
|
2021
Q1 | $11.3M | Buy |
568,982
+263,496
| +86% | +$5.04M | 0.03% | 492 |
|
|
2020
Q4 | $5.33M | Buy |
305,486
+77,496
| +34% | +$1.52M | 0.02% | 678 |
|
|
2020
Q3 | $4.39M | Buy |
227,990
+60,950
| +36% | +$1.31M | 0.02% | 662 |
|
|
2020
Q2 | $3.25M | Buy |
167,040
+10,289
| +7% | +$172K | 0.01% | 724 |
|
|
2020
Q1 | $2.19M | Buy |
+156,751
| New | +$2.57M | 0.01% | 714 |
|
Other funds holding MIRM
FLSM
EAM
BI
NHAS
TCM